Fact CheckerSign in

NCT04644952Recruiting

The Rise in Robotic Atypical Segmentectomies

The Rise in Robotic Atypical Segmentectomies: A Large Cancer Center Experience

Source: ClinicalTrials.gov · Last updated 14 Sept 2026

Brief summary (registry, in English)

This study investigates the increased rate of robotic atypical segmentectomies. Segmentectomy refers to removing a section of a lobe of the lung. Reviewing patients' data retrospectively may help researchers determine whether robotic surgery has led to an increase in atypical segmentectomy.

Status (registry)
Recruiting
Study type
Observational
Enrollment
600 (estimated)
First submitted
19 Nov 2020
Start date
15 Sept 2020
Primary completion date
30 Apr 2027
Lead sponsor
M.D. Anderson Cancer Center
NCT number
NCT04644952

What you commit to

  • Study type: Observational
  • Planned participants: 600
  • From 15 Sept 2020 to the primary completion date, 30 Apr 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • Patients who underwent a lung resection from 2004 to 2019

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
M D Anderson Cancer Center
Coordinator of this site? Confirm its status
HoustonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.